Sarcopedia

BoneDischarge 10 years

Ewing's Sarcoma / Rhabdomyosarcoma - Localised Post Primary Treatment

Ewing's sarcoma, rhabdomyosarcoma, localised post primary treatment

Schedule

1
Year 1
- 2-monthly clinical examination, CXR, plain films of primary bony site; soft tissue tumours - baseline end-of-treatment MRI/CT primary site, thereafter at clinician's discretion; radiotherapy as definitive local treatment - baseline end-of-treatment MRI/CT, then at 6 and 12 months; end of Year 1 - gonadal function and renal function
2
Years 2–3
- 3-monthly clinical examination, CXR, plain films of bony primary site; MRI of soft tissue primary site at clinician's discretion; radiotherapy patients - MRI/CT at 18 and 24 months; MUGA/ECHO 2 years post-diagnosis; annual renal function
3
Year 4
- 6-monthly clinical examination, CXR, plain films of primary site; MRI of soft tissue primary at clinician's discretion; MUGA/ECHO 4 years post-diagnosis; annual renal function
4
Year 5
- 6-monthly clinical examination, CXR, plain films of primary site; annual renal function
5
Years 6–10
- Annual clinical examination, CXR, plain films of primary site; MUGA/ECHO 6 years post-diagnosis; annual renal function

Follow-up Guidelines

25 guidelines — post-treatment surveillance schedules by tumour type and grade

Showing linked guideline: Ewing's Sarcoma / Rhabdomyosarcoma - Localised Post Primary Treatment

Ewing's Sarcoma / Rhabdomyosarcoma - Localised Post Primary Treatment

Ewing's sarcoma, rhabdomyosarcoma, localised post primary treatment

Schedule

1
Year 1
- 2-monthly clinical examination, CXR, plain films of primary bony site; soft tissue tumours - baseline end-of-treatment MRI/CT primary site, thereafter at clinician's discretion; radiotherapy as definitive local treatment - baseline end-of-treatment MRI/CT, then at 6 and 12 months; end of Year 1 - gonadal function and renal function
2
Years 2–3
- 3-monthly clinical examination, CXR, plain films of bony primary site; MRI of soft tissue primary site at clinician's discretion; radiotherapy patients - MRI/CT at 18 and 24 months; MUGA/ECHO 2 years post-diagnosis; annual renal function
3
Year 4
- 6-monthly clinical examination, CXR, plain films of primary site; MRI of soft tissue primary at clinician's discretion; MUGA/ECHO 4 years post-diagnosis; annual renal function
4
Year 5
- 6-monthly clinical examination, CXR, plain films of primary site; annual renal function
5
Years 6–10
- Annual clinical examination, CXR, plain films of primary site; MUGA/ECHO 6 years post-diagnosis; annual renal function

Medical disclaimer

The content on Sarcopedia is for educational and informational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical diagnosis or treatment. Always consult with a qualified physician regarding any health concerns or before starting any new treatment. Reliance on any information provided on this site is solely at your own risk.